等待开盘 05-19 09:30:00 美东时间
+0.160
+1.15%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
Baird analyst Jeff Johnson maintains InMode (NASDAQ:INMD) with a Neutral and lowers the price target from $17 to $14.
05-07 19:33
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
InMode shares are trading lower after the company reported mixed Q1 financial r...
05-07 01:08
InMode (NASDAQ:INMD) reported quarterly earnings of $0.25 per share which missed the analyst consensus estimate of $0.30 by 16.67 percent. This is a 19.35 percent decrease over earnings of $0.31 per share from the same
05-06 19:08
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2026 before the Nasdaq market opens
04-13 19:12
YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive ...
03-24 20:30
BUZZ-U.S. STOCKS ON THE MOVE-Adobe, PAR Technology, Klarna Group Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 13 (Reuters) - U.S. stock index futures inched up in choppy
03-13 19:47
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the
03-13 19:04
YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has auth...
03-13 19:00